Beqalzi (sonrotoclax) is the first BCL2 inhibitor indicated for MCL patients who have progressed after at least 2 lines of therapy, including a BTK inhibitor.

Risk increased for neurological and nonneurological cancers, with highest risk seen within first year of follow-up.

In this study, researchers aimed to investigate whether discontinuing premedications after 2 doses of paclitaxel is safe and feasible in some breast cancer patients.

Researchers explored barriers to colorectal cancer screening uptake in adults aged 45 to 75 years and eligible for colorectal cancer screening.

Researchers assessed whether AI improved the detection and management of incidental lung nodules among adults receiving lung ...

Lower-volume preparation with 1 L polyethylene glycol (PEG)-ascorbate may be an effective and acceptable option for inpatient colonoscopy, according to a study ...

Researchers evaluated whether daraxonrasib, an oral RAS(ON) multiselective inhibitor that targets guanosine triphosphate-bound mutant and wild-type RAS, would be safe and effective in patients with ...

Researchers assessed a multidisciplinary palliative care nursing plan for cancer-related fatigue in patients with advanced lung cancer.

Researchers analyzed national survey data to assess state- and regional-level disparities in HPV vaccine uptake among adolescents.

The COMFORT protocol and other communication strategies that help patients and caregivers understand cancer and its treatment ...

In this study, researchers analyzed a cohort of patients with advanced cancers who received a COVID-19 mRNA vaccine and were treated in a comprehensive cancer center in 2021.

A study conducted during COVID-19 pandemic explored the effects of extending the intervals between implanted vascular access port flushing.